234 related articles for article (PubMed ID: 17549288)
1. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein and the risk of recurrent venous thromboembolism.
Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
[TBL] [Abstract][Full Text] [Related]
6. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
7. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.
Eichinger S; Weltermann A; Minar E; Stain M; Schönauer V; Schneider B; Kyrle PA
Arch Intern Med; 2004 Jan; 164(1):92-6. PubMed ID: 14718328
[TBL] [Abstract][Full Text] [Related]
9. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
10. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
[TBL] [Abstract][Full Text] [Related]
11. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
[TBL] [Abstract][Full Text] [Related]
13. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism.
Jilma B; Kovar FM; Hron G; Endler G; Marsik CL; Eichinger S; Kyrle PA
Arch Intern Med; 2006 Aug 14-28; 166(15):1655-9. PubMed ID: 16908800
[TBL] [Abstract][Full Text] [Related]
14. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
[TBL] [Abstract][Full Text] [Related]
15. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
16. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
[TBL] [Abstract][Full Text] [Related]
18. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
[TBL] [Abstract][Full Text] [Related]
19. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes.
Paneesha S; Cheyne E; French K; Bacchu S; Borg A; Rose P
Br J Haematol; 2006 Oct; 135(1):85-90. PubMed ID: 16925794
[TBL] [Abstract][Full Text] [Related]
20. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]